The Board found that the reduction of the disability evaluation for adenocarcinoma of prostate from 100% to 40% was proper. The RO increased the evaluation to 60%, effective April 3, 2006, but did not find an increase in severity beyond this level.
The deciding factor: The most recent evidence showed no local reoccurrence of adenocarcinoma of the prostate or metastasis, which is required for a higher disability evaluation under DC 7528.
- Claimed conditions
- adenocarcinoma of prostate
- How they argued it
- Secondary to another service-connected condition
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- December 12, 2007
- Citation
- 0739095
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Search VA.gov for the original decision (opens in a new tab) using citation 0739095.
What this means for you
A grant means the Board allowed the benefit or issue identified in this decision. Review the original order: other issues in the same appeal may have a different outcome, and this decision does not predict another claim.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Remanded (sent back)
The Board has found that the receipt of new and relevant evidence is warranted, specifically related to the Veteran's exposure to tetrachlorethylene (TCE) during his service as a fuels specialist. The Board will remand for readjudication based on this new evidence.
- Whole decision: Remanded (sent back)
The Veteran's claim for a higher rating for prostate cancer residuals is being remanded due to the failure of the Veteran to report for a scheduled VA examination. The case will be reconsidered with a new examination.
- Whole decision: Dismissed
The Veteran's claim for service connection for depression associated with adenocarcinoma of prostate is dismissed as the issue has been resolved in his favor.
- Whole decision: Denied
The Veteran's claim for higher disability ratings for prostate cancer and TDIU was denied. The rating reduction from 100% to 40% disabling for prostate cancer, effective August 1, 2015, and then from 40% to 20% in December 1, 2017, were upheld.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.